Organovo Holdings Inc
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with … Read more
Organovo Holdings Inc (ONVO) - Total Liabilities
Latest total liabilities as of December 2024: $3.48 Million USD
Based on the latest financial reports, Organovo Holdings Inc (ONVO) has total liabilities worth $3.48 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Organovo Holdings Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Organovo Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Organovo Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Organovo Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Permsin Steel Works Public Company Limited
BK:PERM
|
Thailand | ฿3.60 Billion |
|
Panca Mitra Multiperdana Tbk PT
JK:PMMP
|
Indonesia | Rp228.12 Million |
|
Rani Zim Shopping Centers
TA:RANI
|
Israel | ILA2.33 Billion |
|
Golden Tobacco Limited
NSE:GOLDENTOBC
|
India | ₹2.05 Billion |
|
Goff Corp
PINK:WNFT
|
USA | $391.41K |
|
MASTEC (MY8.SG)
STU:MY8
|
Germany | €5.93 Billion |
|
ClearStream Energy Services Inc
PINK:NWPIF
|
USA | $149.42 Million |
|
Indosterling Technomedia Tbk
JK:TECH
|
Indonesia | Rp9.60 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Organovo Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Organovo Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Organovo Holdings Inc (2011–2024)
The table below shows the annual total liabilities of Organovo Holdings Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-03-31 | $2.75 Million | -44.86% |
| 2023-03-31 | $4.98 Million | +61.45% |
| 2022-03-31 | $3.09 Million | +328.16% |
| 2021-03-31 | $721.00K | -60.17% |
| 2020-03-31 | $1.81 Million | -58.15% |
| 2019-03-31 | $4.33 Million | -17.48% |
| 2018-03-31 | $5.24 Million | -23.13% |
| 2017-03-31 | $6.82 Million | +26.38% |
| 2016-03-31 | $5.39 Million | +12.56% |
| 2015-03-31 | $4.79 Million | +152.00% |
| 2014-03-31 | $1.90 Million | -91.37% |
| 2013-03-31 | $22.05 Million | +206147.66% |
| 2012-03-31 | $10.69K | 0.00% |
| 2011-03-31 | $10.69K | -- |